• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Director Dalto Juan Carlos

    4/2/25 8:49:04 AM ET
    $LWAY
    Packaged Foods
    Consumer Staples
    Get the next $LWAY alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Dalto Juan Carlos

    (Last) (First) (Middle)
    C/O LIFEWAY FOODS, INC.
    6431 WEST OAKTON

    (Street)
    MORTON GROVE IL 60053

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Lifeway Foods, Inc. [ LWAY ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    03/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 4,751 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) (1) (1) Common Stock 1,600 1,600 D
    Restricted Stock Units (2) (2) (2) Common Stock 3,101 3,101 D
    Restricted Stock Units (3) (3) (3) Common Stock 4,066 4,066 D
    Phantom Stock (4) 03/31/2025 A 461 (4) (4) Common Stock 461 $0 461 D
    Explanation of Responses:
    1. Each restricted stock unit ("RSU") has a value equal to one share of common stock. The remaining RSUs will vest on August 31, 2025, contingent on the Reporting Person's continued service as a Director on the vesting date.
    2. Each RSU has a value equal to one share of common stock. Of such RSUs, 1,551 will vest on August 31, 2025 and 1,550 will vest on August 31, 2026, contingent on the Reporting Person's continued service as a Director on each applicable vesting date.
    3. Each RSU has a value equal to one share of common stock. Of such RSUs, 1,356 will vest on each of July 1, 2025 and 2026 and 1,354 will vest on July 1, 2027, contingent on the Reporting Person's continued service as a Director on each applicable vesting date.
    4. Each share of phantom stock has a value equal to one share of common stock. The acquired shares of phantom stock were acquired upon deferral of the Reporting Person's cash compensation for service on the Board of Directors in the quarter ended March 31, 2025. The phantom stock becomes payable on the date that the Reporting Person no longer serves as a director of the Company.
    /s/ Eric Hanson, as attorney-in-fact 04/02/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $LWAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LWAY

    DatePrice TargetRatingAnalyst
    9/24/2024Outperform → Market Perform
    Noble Capital Markets
    5/30/2024$20.00Market Perform → Outperform
    Noble Capital Markets
    4/5/2024$25.00Buy
    Lake Street
    3/27/2024Outperform → Market Perform
    Noble Capital Markets
    2/26/2024$14.00Market Perform → Outperform
    Noble Capital Markets
    11/27/2023Outperform → Market Perform
    Noble Capital Markets
    11/14/2023$13.00Market Perform → Outperform
    Noble Capital Markets
    9/25/2023Outperform → Market Perform
    Noble Capital Markets
    More analyst ratings

    $LWAY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 4:33:49 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      11/15/24 8:53:57 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

      SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

      9/23/24 4:07:26 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Edward Smolyansky Rebukes Lifeway Foods (NASDAQ: LWAY) 2024 Amended 10-K Filing

      CHICAGO, May 2, 2025 /PRNewswire/ -- Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation. Apparent Delay of 2025 Annual Meeting of Shareholders On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate. "The filing of the amended 2024 Annual Report, and other steps taken recently by the Company,

      5/2/25 12:50:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    SEC Filings

    See more
    • SEC Form 10-Q filed by Lifeway Foods Inc.

      10-Q - Lifeway Foods, Inc. (0000814586) (Filer)

      5/13/25 9:00:23 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 6:46:02 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Amendment: SEC Form 10-K/A filed by Lifeway Foods Inc.

      10-K/A - Lifeway Foods, Inc. (0000814586) (Filer)

      4/29/25 4:15:08 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, President and Secretary Smolyansky Julie sold $1,103,500 worth of shares (50,000 units at $22.07), decreasing direct ownership by 2% to 2,132,483 units (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/20/25 3:12:39 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $891,927 worth of shares (37,482 units at $23.80) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/5/25 4:50:03 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Member of 10% owner group Smolyansky Ludmila sold $487,769 worth of shares (20,518 units at $23.77) (SEC Form 4)

      4 - Lifeway Foods, Inc. (0000814586) (Issuer)

      5/1/25 5:01:56 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples

    $LWAY
    Financials

    Live finance-specific insights

    See more

    $LWAY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lifeway Foods EPS Increases 44% Year-Over-Year as Kefir Company Announces Results for the First Quarter Ended March 31, 2025

      Net sales of $46.1 million; up 3.3% year-over-year Consumer demand for probiotic Lifeway products drives 22nd consecutive quarter of year-over-year sales growth MORTON GROVE, Ill., May 13, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the first quarter ended March 31, 2025. "We're thrilled to begin 2025 with continued topline momentum, delivering our 22nd consecutive quarter of year-over-year net sales growth," comme

      5/13/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Record Week Surpassing $5 Million in Gross Sales Propelled by Strong Demand for Lifeway Kefir and Lifeway Farmer Cheese

      Company to Report First Quarter 2025 Results on May 13, 2025 MORTON GROVE, Ill., April 29, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced a milestone achievement of surpassing $5 million in gross sales for the week ending April 27th, 2025, representing a 35% increase from the prior year. The Company expects to report financial results for the first quarter ended March 31, 2025 on May 13, 2025 before market hours. A pre-recorded con

      4/29/25 6:45:00 PM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

      Company achieves 2024 net sales of $186.8 million; up 17% year-over-year 21st consecutive quarter of year-over-year growth Growing consumer interest in probiotic foods with bioavailable nutrients continues to drive strong demand for Lifeway products MORTON GROVE, Ill., March 14, 2025 /PRNewswire/ -- Lifeway Foods, Inc. (NASDAQ:LWAY) ("Lifeway" or "the Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, reported financial results for the fourth quarter and full year ended December 31, 2024. "I am pleased to report another reco

      3/14/25 9:00:00 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods downgraded by Noble Capital Markets

      Noble Capital Markets downgraded Lifeway Foods from Outperform to Market Perform

      9/24/24 8:32:49 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lifeway Foods upgraded by Noble Capital Markets with a new price target

      Noble Capital Markets upgraded Lifeway Foods from Market Perform to Outperform and set a new price target of $20.00

      5/30/24 9:15:56 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples
    • Lake Street initiated coverage on Lifeway Foods with a new price target

      Lake Street initiated coverage of Lifeway Foods with a rating of Buy and set a new price target of $25.00

      4/5/24 8:42:53 AM ET
      $LWAY
      Packaged Foods
      Consumer Staples